Display Settings:

Format

Send to:

Choose Destination

    Respir Res. 2001;2(2):80-4. Epub 2001 Feb 15.

    Th2 cytokines and asthma. Interleukin-9 as a therapeutic target for asthma.

    Zhou Y, McLane M, Levitt RC.

    Magainin Pharmaceuticals Inc, Plymouth Meeting, Pennsylvania 19462, USA.

    Asthma is a complex heritable inflammatory disorder of the airways in which the development of clinical disease depends on environmental exposure. It has been well established that T helper type 2 (TH2) lymphocytes and their cytokines have an important role in allergic asthma. Interleukin (IL)-9, a member of the TH2 cytokine family, has recently been implicated as an essential factor in determining mucosal immunity and susceptibility to atopic asthma. In this review we examine the critical experiments and observations that support this hypothesis. We also discuss these results in comparison with the experiments supporting the involvement of other T H2 cytokines such as IL-4, IL-5 and IL-13.

    PMID: 11686869 [PubMed - indexed for MEDLINE]

    PMCID: 59572

    Supplemental Content

    Click here to read Click here to read